Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis
about
Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene productEfflux-mediated drug resistance in bacteria: an updatePhenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosaMutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosaInduction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interactionEfflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneMucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesClonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacinDevelopment and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patientsInfluence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.Aminoglycoside resistance in Pseudomonas aeruginosa.Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.Efflux-mediated antimicrobial resistance.Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa.MexXY multidrug efflux system of Pseudomonas aeruginosa.Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in VirulenceEfflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosaAdaptive and mutational resistance: role of porins and efflux pumps in drug resistance.The TetR family of regulators.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Evolution of Drug Resistance in Bacteria.MexY-promoted aminoglycoside resistance in Pseudomonas aeruginosa: involvement of a putative proximal binding pocket in aminoglycoside recognition.Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms.Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa.Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates.Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosaDistribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species.
P2860
Q24542408-4E06EF54-6192-4C34-92F8-3269482C0E5CQ24609407-81D0A601-7F4D-42F1-9F31-CB2CA6D97535Q28478449-8688DB2D-05D1-4DD2-B2A5-587ADCEC7151Q28492617-784893E8-7685-4E66-BD2D-57D41A4E4987Q28492803-5CF68EB3-7B24-4829-A807-A3A912766453Q33251206-B7D3958C-1A94-4946-845A-627EADC1FC8FQ33267866-204D5395-2F78-4142-9C5E-778630AACD8EQ33831880-BF09DDD4-659D-4999-BB82-FD09E92D0103Q33911762-C5C7A2B7-E62C-4D61-9F87-69185B7501D6Q34117477-2E7C4BE7-2FD5-479E-A08B-BD95C7428354Q34648729-5EB68145-7ADD-42A3-9698-F481381B6556Q34948367-82FE439D-8EBF-492C-BEC5-8EAA22A77ED6Q35007624-9EAF3E8C-60A3-4435-A4C8-BCBAE2044E6EQ35482558-3A3D3D8B-9194-449A-902B-6F80F3AC985DQ35598576-BCB22A84-BBCC-4BAB-B808-513F4D06D7BDQ35758992-B43D96D7-323E-4390-BD2C-13571BFE2F50Q35879111-B4263B48-E688-4997-8AB0-6F83E262DF36Q36021296-795C620F-49B1-47FC-8A81-AF26785F1189Q36095065-D811F5F0-0E49-471B-9BC1-0A48837D5F95Q36138147-006304D2-E6EC-4750-96A3-6A1388D9280DQ36313190-761E3BDC-2B8B-448F-B831-E97B185879CCQ36450695-18305C17-0AAE-4CB4-8F66-DB4E180E511AQ36683498-DAD38945-CAC8-4D5E-B6F7-9BCD6440A181Q37190771-570FD517-298D-41BA-8B42-DEAB365EC9EBQ37544527-CC99A084-5B13-4FA3-B9B7-A92A69404316Q38049220-1EA32E75-4CE2-417B-8E3B-39772D713D0DQ38134377-C5C3F8D5-F81D-4B38-9795-5F24224A9C3FQ38599969-D3AC3EC9-1B6C-439B-AEE8-BD9433832271Q38837707-D9EE7CA2-6F68-436F-9340-C06CEDD6C46CQ38873261-003F0E10-E2FC-4ED2-AFBC-D1AC517BD540Q40184199-8B40DA6A-86FB-4EBC-B0A4-05437C4B485FQ40368641-D04B9E2E-52ED-4A93-8E8F-EE62761F5A6DQ40696824-1065AB91-A314-4459-9365-4D5493143E11Q40721650-A3485EE5-97C2-42EF-828A-D6EC85F6838EQ40815891-7BD13BD5-46E4-407D-ACE7-586D41D5BBD4Q41060499-53B5CFEE-E4AC-4077-A40C-8CF0483C40D1Q41415884-0FE106B3-5092-4B41-92FA-8481EA409135Q41465136-0840D298-B5DA-4B8A-81A3-4F43C3C46D71Q41827007-3CCEEB16-99AC-4E80-98A9-441E9FB83B1AQ41836400-A546B199-9FA7-40FC-A949-982E0BD2C390
P2860
Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis
description
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Mai 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/05/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/05/01)
@nl
наукова стаття, опублікована в травні 2004
@uk
مقالة علمية (نشرت في مايو 2004)
@ar
name
Role of the multidrug efflux s ...... patients with cystic fibrosis
@ast
Role of the multidrug efflux s ...... patients with cystic fibrosis
@en
Role of the multidrug efflux s ...... patients with cystic fibrosis
@nl
type
label
Role of the multidrug efflux s ...... patients with cystic fibrosis
@ast
Role of the multidrug efflux s ...... patients with cystic fibrosis
@en
Role of the multidrug efflux s ...... patients with cystic fibrosis
@nl
prefLabel
Role of the multidrug efflux s ...... patients with cystic fibrosis
@ast
Role of the multidrug efflux s ...... patients with cystic fibrosis
@en
Role of the multidrug efflux s ...... patients with cystic fibrosis
@nl
P2093
P2860
P921
P1476
Role of the multidrug efflux s ...... patients with cystic fibrosis
@en
P2093
Christelle Vogne
Christiane Bailly
Didier Hocquet
Julio Ramos Aires
Patrick Plésiat
P2860
P304
P356
10.1128/AAC.48.5.1676-1680.2004
P407
P577
2004-05-01T00:00:00Z